Will genetic advances address health disparities? Not much unless they are accessible.

The new issue of Health Affairs looks at health policy and health disparities. Many local researchers represented. Of interest: Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.  The authors include two local researchers: Katherine L. Tucker is a professor in clinical laboratory and nutritional sciences at the University of Massachusetts, in Lowell...José M. Ordovás is … Continue reading Will genetic advances address health disparities? Not much unless they are accessible.

Advertisements

From ob/gyn to surgery, MGH study found salaries for male doctors higher than #female #doctors at public US #medical #schools

From JAMA Internal Medicine: Question Do differences in salary exist between male and female academic physicians in US public medical schools? Relying on Freedom of Information laws that mandate release of salary information of public university employees in several states, this study analyzed sex differences in academic physician salary among 10 241 physicians in 24 public … Continue reading From ob/gyn to surgery, MGH study found salaries for male doctors higher than #female #doctors at public US #medical #schools

#Massachusetts cares if #doctors have conflicts of interest, but do #patients care?

The Globe offers a peek at the drug company marketing/meals at smaller hospitals Years after many big academic medical centers cracked down on industry perks, drug companies still regularly buy meals for doctors affiliated with smaller hospitals, a new analysis shows, with some physicians receiving dozens of lunches and dinners in a single year. At a number … Continue reading #Massachusetts cares if #doctors have conflicts of interest, but do #patients care?

NEJM: One man’s tragic try at “stem cell” therapy. Will we soon be seeing ads for overseas CRISPR clinics?

A local man has been crippled by a growth on his spine that developed after he traveled overseas to a so- called stem cell clinic. The growth was not from his own cells. So, not only is the treatment untested, doctors don't know what to do about the bad outcomes. Here's the technical explanation from … Continue reading NEJM: One man’s tragic try at “stem cell” therapy. Will we soon be seeing ads for overseas CRISPR clinics?

My father’s brain is missing  

Certain that years of meds, scotch, steak and surliness had gotten to my Mad Men-era dad, we agreed to donate his brain to Harvard. He came up clean - not a trace of damage or plaque. The findings are actually missing, not the samples. The Boston Globe reports: McLean Hospital said Tuesday that information about … Continue reading My father’s brain is missing  

Should the FDA approve Vertex’s new cystic fibrosis drug?

The scene at the FDA hearing was familiar. All the  advisory committees have seen it play out again and again. Yesterday, it was the Pulmonary-Allergy Drug committee: The pharma doc with the convincing statement. The weeping patients. The drug likely to cost a couple thousand a month offering a slim  benefit over an existing drugs. … Continue reading Should the FDA approve Vertex’s new cystic fibrosis drug?

2 Boston studies: Breast cancer costs and medical records benefits

After pushing mammograms for years, breast cancer advocates have had a hard time pulling back. Still the evidence keep piling up that message about surviving breast cancer is more complicated than early detection.  What this study by Boston researchers doesn't measure: the scores of women who say -- If there's a chance it's cancer, I … Continue reading 2 Boston studies: Breast cancer costs and medical records benefits